Driving Progress for an Oral BRD9 Bifunctional Degrader
Time: 10:00 am
day: Day 1
Details:
- Identifying potent, selective, and orally bioavailable BiDAC™ degrader of BRD9
- Showcasing a world-class degrader platform demonstrates effective degradation of previously undruggable target
- Presenting initial clinical data for dose finding escalation cohorts
